Valuation: Shandong Weigao Group Medical Polymer Company Limited

Market Cap 13.3B 1.97B 1.7B 1.6B 1.46B 2.74B 189B 2.78B 18.76B 7.33B 94.45B 7.41B 7.25B 314B P/E 2026 *
8.45x
P/E 2027 * 6.71x
Enterprise Value 7.63B 1.13B 978M 919M 835M 1.57B 108B 1.6B 10.76B 4.21B 54.2B 4.25B 4.16B 180B EV / Sales 2026 *
0.55x
EV / Sales 2027 * 0.45x
Free-Float
51.42%
Yield 2026 *
5.19%
Yield 2027 * 6.21%
Manager TitleAgeSince
Chief Executive Officer 45 2021-03-29
Chief Executive Officer 52 2018-07-31
Director of Finance/CFO 48 2001-06-30
Director TitleAgeSince
Chairman 52 2021-03-29
Director/Board Member 51 2021-03-07
Director/Board Member 55 2021-03-07
Change 5-day change 1-year change 3-year change Capi.($)
-19.05%-.--% - - 1.97B
-0.49%-2.10%-29.04%-47.98% 14.94B
-3.07%-4.93%+27.35%+119.91% 4.61B
-0.78%-2.11%+252.70%+197.44% 3.27B
-0.92%-1.76%-28.84%-30.69% 2.51B
-0.98%-1.04%-30.87%-28.56% 1.86B
0.00%+3.97%+9.17%-18.63% 1.29B
+3.08%+2.66%+5.46%-12.54% 1.09B
-0.89%-3.42%-4.50%+13.97% 983M
-1.19%-1.78%+20.29%+31.75% 974M
Average -2.43%-0.10%+24.64%+24.96% 3.5B
Weighted average by Cap. -1.92%-1.51%+13.35%+11.36%

Financials

2026 *2027 *
Net sales 14B 2.08B 1.79B 1.68B 1.53B 2.88B 198B 2.93B 19.74B 7.72B 99.39B 7.79B 7.62B 330B 15.14B 2.24B 1.94B 1.82B 1.66B 3.11B 215B 3.17B 21.35B 8.35B 107B 8.43B 8.24B 357B
Net income 1.6B 237M 204M 192M 175M 328M 22.63B 334M 2.25B 880M 11.33B 889M 869M 37.67B 1.99B 295M 254M 239M 217M 409M 28.17B 416M 2.8B 1.1B 14.11B 1.11B 1.08B 46.87B
Net Debt -5.67B -841M -726M -682M -621M -1.17B -80.39B -1.19B -7.99B -3.13B -40.26B -3.16B -3.09B -134B -6.53B -969M -837M -786M -715M -1.34B -92.63B -1.37B -9.21B -3.6B -46.39B -3.64B -3.56B -154B
Logo Shandong Weigao Group Medical Polymer Company Limited
Shandong Weigao Group Medical Polymer Co Ltd is a China-based company principally engaged in the research and development, production and sale of medical device products. The Company operates its businesses through six segments. The Medical Device Products segment produces and sells clinical care, medical testing, anesthesia and surgical related products and other consumables. The Orthopaedic Products segment produces and sells orthopaedic products, including tissue repair product line. The Interventional Products segment produces and sells tumour and blood vessel interventional instruments. The Pharma Packaging Products segment produces and sells pre-filled syringes and flushing syringes. The Blood Management Products segment produces and sells blood collection, irradiation, storage, separation and sterilization products. The Others segment engages in finance lease and factoring business. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BB